Article
Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.
Hematology. American Society of Hematology. Education Program - 1 Jan 2009
Rodeghiero Francesco, Castaman Giancarlo, Tosetto Alberto
Abstract excerpt
The wide clinical spectrum of von Willebrand disease (VWD), its complex pathophysiology and its classification into distinct quantitative (type 1 or type 3) and qualitative (type 2) types with further subtle distinctions have prevented most clinicians from establishing a straightforward approach...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
